Skip to main content
News University of Excellence 07.2019
University of Excellence - Rector Prof. Dr. Dr. h.c. Michael Hoch celebrates the excellence decision
© Barbara Frommann/Uni Bonn

Honors & Funding

“We are a University of Excellence”

The University of Bonn is one of only eleven Universities of Excellence in Germany appointed today and one of two in North Rhine-Westphalia. With the six Clusters of Excellence acquired last September, the University of Bonn is the most successful university in the Germany-wide Excellence competition. We are happy and proud to be part of that excellent University.

We look forward to continue our excellent research in this great scientific environment.

Related news

Niklas Klümper

Honors & Funding

Niklas Klümper Receives Johann-Georg-Zimmermann Prize

—PD Dr. Niklas Klümper was honored with the prestigious Johann-Georg-Zimmermann Research Prize. The €10,000 award is presented annually to young cancer researchers for their current scientific contributions.
View entry
Speakers of ImmunoSensation

Honors & Funding

ImmunoSensation goes into the next round

—The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry
Kerstin Ludwig

Honors & Funding

Genome data to improve diagnosis and treatment of long Covid

—Despite the many advances, there are still major gaps in the care of patients with long-term and post-COVID. The Institute of Human Genetics at the UKB in Bonn now begins a genomLC study as part of a BMG funding priority. The researchers want to help speed up the diagnosis of long- and post-COVID and identify possible biomarkers that could possibly also differentiate between subgroups of the diseases. To this end, the genomic data of those affected is being analyzed as part of a study using blood samples. The project is funded by the Federal Ministry of Health (BMG) with 1.34 million euros.
View entry

Back to the news overview